Troscan 500 Mg Film-Coated Tablets
Revised: October 2013
AN: 00973/2013
SUMMARY OF PRODUCT CHARACTERISTICS
1. NAME OF THE VETERINARY MEDICINAL PRODUCT
Troscan 500 mg Film-Coated Tablets
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
Active substances:
Nitroscanate 500 mg
Excipient(s):
Titanium Dioxide (E171) 0.8038 mg
Ferric Oxide Yellow (E172) 0.0257 mg
Ferric Oxide Black (E172) 0.00003 mg
Ferric Oxide Red (E172) 0.00003 mg
As constituents of Opadry OY-GM 7900
For the full list of excipients, see section 6.1.
3. PHARMACEUTICAL FORM
Film-coated tablet.
Round convex tablets, yellow coloured, film coated.
4. CLINICAL PARTICULARS
4.1 Target species
Dogs.
4.2 Indications for use, specifying the target species
Is a broad spectrum anthelmintic for use in adult dogs. Is highly effective in the control of cestodes and common intestinal nematodes: Toxocara canis, Toxascaris leonina, Uncinaria stenocephala, Ancylostoma caninum, Taenia hydatigena, Taenia pisiformis, and Dipylidium caninum. Gives a limited level of control of Echinococcus granulosus
4.3 Contraindications
When administered as recommended is unlikely to cause vomiting. Do not repeat treatment if
vomiting occurs shortly after dosing. Do not administer to sick or convalescing animals. If a hypersensitivity reaction occurs treatment should be discontinued.
4.4 Special warnings for each target species
Is not indicated for the treatment of Trichuris vulpis. It is recommended that adult dogs should be wormed routinely 2 - 4 times a year. Since the most common tapeworm of the dog (Dipylidium caninum) is transmitted by a flea and has a very short pre-patent period, it is important to pay attention to flea control to reduce the incidence of tapeworm in your pet.
It is important to worm young puppies very regularly for roundworm with Troscan 100 at 2 weekly intervals from the age of 2 weeks for pups less than 8 weeks of age. It is then recommended that Troscan 100 be used at 8, 12, 16, and 24 weeks of age. Nursing bitches should be treated at the same time and as frequently as puppies up to 12 weeks of age. Thereafter the adult worming regime of 2 - 4 times a year is recommended. If symptoms of disease persist or appear, consult your veterinary surgeon.
4.5 Special precautions for use
i Special precautions for use in animals
Is irritant, tablets should not be broken.
ii Special precautions to be taken by the person administering the veterinary medicinal product to animals
This product can be an irritant to the skin and eyes. Tablets are film-coated and should not be broken or divided.
4.6 Adverse reactions (frequency and seriousness)
None Known.
4.7 Use during pregnancy, lactation or lay
Can be safely used during pregnancy and lactation.
4.8 Interaction with other medicinal products and other forms of interaction
None known
4.9 Amounts to be administered and administration route
The dose for the routine treatment of adult dogs is nitroscanate 50mg/kg bodyweight, which is equivalent to 1 x 500 mg tablet per 10 kg (22 lb) bodyweight. Adult dogs should be dosed 2 – 4 times a year.
Should be administered orally in the morning after overnight fasting with approximately one-fifth of the daily food ration. The remaining food ration should be withheld for at least 8 hours.
4.10 Overdose (symptoms, emergency procedures, antidotes), if necessary
Refer to 4.4 if signs of overdose occur. Treat symptomatically.
4.11 Withdrawal period
Not applicable
5. PHARMACOLOGICAL PROPERTIES AND PHARMACOKINETIC PARTICULARS
ATCvet Code QP52AX01
Nitroscanate is a broad spectrum anthelmintic effective against gastrointestinal nematodes and cestodes.
6. PHARMACEUTICAL PARTICULARS
6.1 List of excipients
Opadry-Oy-GM 7900, consisting of:
Titanium Dioxide (E171)
Ferric Oxide Yellow (E172)
Ferric Oxide Black (E172)
Ferric Oxide Red (E172)
Sodium Starch Glycollate
Maize Starch
Microcrystalline Cellulose
Sodium Lauryl Sulphate
Magnesium Stearate
6.2 Incompatibilities
None known
6.3 Shelf life
Shelf life of the veterinary medicinal product as packaged for sale: 5 years
6.4. Special precautions for storage
Store in a dry place.
Do not store above 25°C
6.5 Nature and composition of immediate packaging
Aluminium foil, low density polyethylene strips in outer carton containing
100 tablets or 60 tablets (for sale to veterinary surgeons only)
1 x 1 for OTC sale
1 x 4 for OTC sale
Not all pack sizes may be marketed
6.6 Special precautions for the disposal of unused veterinary medicinal product or waste materials derived from the use of such products, if appropriate
Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal product should be disposed of in accordance with local requirements.
7. MARKETING AUTHORISATION HOLDER
Chanelle Animal Health Ltd.,
7 Rodney Street
Liverpool L1 9HZ
UK.
8. MARKETING AUTHORISATION NUMBER
11990/4010
9. DATE OF FIRST AUTHORISATION
27 January 1994
10 DATE OF REVISION OF THE TEXT
October 2013
04 Decemebr 2013
Page 4 of 4